Today: 11 June 2026
Morgan Stanley Upgrade Lifts MDA Space as 2026 Space-Tech Funding Forecast Rises

Morgan Stanley Upgrade Lifts MDA Space as 2026 Space-Tech Funding Forecast Rises

TORONTO, Jan 19, 2026, 11:19 EST

Global investment in space technology is set to climb again in 2026 after a record year, driven by defense-linked satellite systems and launch capacity, investment firm Seraphim Space said on Monday. Private investment rose 48% in 2025 to $12.4 billion, the firm said, and “a potential SpaceX IPO could act as a powerful catalyst,” said Seraphim Space investment analyst Lucas Bishop. The update lands as Canada’s MDA Space jumped 14.5% on Friday after Morgan Stanley upgraded the stock, a move that helped keep Toronto’s main index near record levels. Reuters

Morgan Stanley’s space team, led by analyst Kristine Liwag, has an “attractive” view on the sector for 2026, TipRanks reported, pointing to tailwinds that it says should carry over from last year. Gains are expected to be “fueled by higher launch cadences, new product intros, policy support & market maturation,” Liwag wrote, flagging Rocket Lab (RKLB), AST SpaceMobile (ASTS) and Intuitive Machines (LUNR). TipRanks

The bank upgraded Rocket Lab and MDA Space (MDA.TO) to “overweight” — Wall Street shorthand for expecting outperformance — and raised its Rocket Lab price target to $105 from $67, Investing.com reported. Liwag called 2025 “a banner year” for the space industry and said Rocket Lab could complete its first Neutron launch in early 2026 while lifting Electron’s launch cadence; for MDA, the bank lifted its target to C$46 from C$32. Investing.com South Africa

Canadian stocks were softer on Monday morning after U.S. President Donald Trump threatened new tariffs on eight European countries, with the benchmark S&P/TSX Composite Index down 0.1% by 10:12 a.m. ET, Reuters reported. “It’s not surprising to see volatility,” said Josh Sheluk, a portfolio manager at Verecan Capital Management, while volumes were expected to be lighter with U.S. markets closed for Martin Luther King Jr. Day. Reuters

MDA has also been leaning harder into defense-linked work. The company said earlier this month it received an indefinite-delivery/indefinite-quantity contract — an umbrella deal that allows agencies to issue task orders over time — from the U.S. Missile Defense Agency for its SHIELD program. “Our selection for the Missile Defense Agency SHIELD IDIQ is a recognition of the technology, talent and expertise MDA Space offers,” CEO Mike Greenley said. PR Newswire

MDA’s shares rose 6.6% on Jan. 8 after the company said it was selected by the Missile Defense Agency for SHIELD, Reuters reported at the time.

MDA is a space mission partner spanning satellite systems, robotics and space operations, and geointelligence, according to Reuters company data. Its customers range across commercial and government space programs.

But the trade can turn quickly in a sector still tied to big contract wins and schedule risk. Morgan Stanley noted MDA shares had fallen about 28% since EchoStar scrapped a roughly $1.3 billion “direct-to-device” satellite project in late 2025 — a setback for a market that aims to connect phones directly to satellites — even as the bank argued MDA trades at a steep valuation discount to peers and has a “bright catalyst path” this year. Investing.com

For investors, the next tests are plain: launches that happen when promised, defense task orders that convert from eligibility to revenue, and whether the IPO window opens wider for space companies beyond a small set of public names.

Stock Market Today

  • PIMCO ETFs PLC Declares Key Dividend Dates for June 2026
    June 11, 2026, 10:57 AM EDT. PIMCO ETFs PLC announced important dividend-related dates: a record date on June 17, 2026, followed by a pay date on June 18, 2026. The ex-dividend date, which is the cutoff to buy the ETF to receive the dividend, is set for June 11, 2026. These dates are critical for investors tracking income and dividend payouts from PIMCO ETFs, signaling when shares must be held to qualify for dividend payments.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Tencent stock falls to HK$610 — what investors watch next after China growth data
Previous Story

Tencent stock falls to HK$610 — what investors watch next after China growth data

Nestle stock price falls in Zurich on tariff jitters; what investors watch before Feb. 19 results
Next Story

Nestle stock price falls in Zurich on tariff jitters; what investors watch before Feb. 19 results

Go toTop